Michael Megna

Track

Insider profile

Currently holds a position at Kiniksa Pharmaceuticals Ltd

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Principal Financial Officer, Chief Accounting Officer Kiniksa Pharmaceuticals Ltd March 20, 2020 -
Chief Accounting Officer, Vice President - Finance Kiniksa Pharmaceuticals Ltd Feb. 4, 2020 - March 20, 2020
Vice President - Finance Kiniksa Pharmaceuticals Ltd July 1, 2018 - Feb. 4, 2020
Michael Megna's trades of Kiniksa Pharmaceuticals Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
340.24
Quantity 33,002
Value US$806,638
Transaction date
Proposed sale
Price
34.84
Quantity 11,000
Value US$383,203
Transaction date
Proposed sale
Price
32.35
Quantity 17,000
Value US$549,936
Transaction date
Proposed sale
Price
28.75
Quantity 15,211
Value US$437,330
Transaction date
Proposed sale
Price
26.69
Quantity 17,647
Value US$471,014
Transaction date
Proposed sale
Price
22.45
Quantity 9,051
Value US$203,207
Transaction date
Sale
Price
19.13
Quantity 9,316 -35.4%
Value US$178,215
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-13 2026-04-09
PlS Planned sale
68,502 +42.1%
14.90
US$4,784,851 		68,502 +42.1% 14.90 US$4,784,851
2026-04-09 2026-04-09
PrS Proposed sale
33,002
340.24
US$806,638 		33,002 340.24 US$806,638
2025-10-22 2025-10-20
PlS Planned sale
85,153 +19.6%
320.02
US$2,416,754 		85,153 +19.6% 320.02 US$2,416,754
2025-10-22 2025-10-20
PlS Planned sale
37,255 -48.0%
38.72
US$1,442,514 		37,255 -48.0% 38.72 US$1,442,514
2025-10-20 2025-10-20
PrS Proposed sale
50,490
38.88
US$1,962,914 		50,490 38.88 US$1,962,914
2025-09-03 2025-09-03
PrS Proposed sale
11,000
34.84
US$383,203 		11,000 34.84 US$383,203
2025-09-03 2025-09-03
PlS Planned sale
11,000 -22.4%
34.84
US$383,240 		11,000 -22.4% 34.84 US$383,240
2025-08-06 2025-08-04
PlS Planned sale
17,000 -34.0%
32.35
US$549,950 		17,000 -34.0% 32.35 US$549,950
2025-08-04 2025-08-04
PrS Proposed sale
17,000
32.35
US$549,936 		17,000 32.35 US$549,936
2025-06-05 2025-06-03
PlS Planned sale
15,211 -31.9%
28.75
US$437,316 		15,211 -31.9% 28.75 US$437,316
2025-06-03 2025-06-03
PrS Proposed sale
15,211
28.75
US$437,330 		15,211 28.75 US$437,330
2025-05-09 2025-05-07
PlS Planned sale
17,647 -35.2%
26.69
US$470,998 		17,647 -35.2% 26.69 US$470,998
2025-05-07 2025-05-07
PrS Proposed sale
17,647
26.69
US$471,014 		17,647 26.69 US$471,014
2025-03-14 2025-03-12
PlS Planned sale
9,051 -25.4%
22.45
US$203,195 		9,051 -25.4% 22.45 US$203,195
2025-03-12 2025-03-12
PrS Proposed sale
9,051
22.45
US$203,207 		9,051 22.45 US$203,207
2024-12-02 2024-11-29
PlS Planned sale
9 -0.0%
22.45
US$202 		9 -0.0% 22.45 US$202
2024-12-02 2024-11-27
PlS Planned sale
8,637 -24.6%
22.45
US$193,901 		8,637 -24.6% 22.45 US$193,901
2024-11-27 2024-11-27
PrS Proposed sale
17,697
22.45
US$397,298 		17,697 22.45 US$397,298
2024-03-01 2024-03-01
PlS Planned sale
9,659 -35.4%
21.45
US$207,186 		9,659 -35.4% 21.45 US$207,186
2024-03-01 2024-02-28
PlS Planned sale
5,126 -22.6%
21.79
US$111,696 		5,126 -22.6% 21.79 US$111,696
2024-02-28 2024-02-28
PrS Proposed sale
14,785
21.45
US$317,138 		14,785 21.45 US$317,138
2024-01-04 2024-01-02
PlS Planned sale
16,670 -49.5%
19.17
US$319,564 		16,670 -49.5% 19.17 US$319,564
2023-12-21 2023-12-19
S Sale
9,316 -35.4%
19.13
US$178,215 		9,316 -35.4% 19.13 US$178,215
2023-12-19 2023-12-19
PrS Proposed sale
25,986
19.13
US$497,125 		25,986 19.13 US$497,125